Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutic preparation of losartan potassium

A technology for losartan potassium and pharmaceutical preparations, which is applied in directions such as pharmaceutical combinations, pharmaceutical formulations, and non-active ingredients medical preparations, can solve the problems of long mixing process time, high viscosity of materials, influence on drug efficacy, etc., and achieves excellent flow performance, improve stability, and improve water absorption

Active Publication Date: 2019-03-19
BEIJING WINSUNNY PHARMA CO LTD
View PDF8 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Losartan potassium has the characteristics of strong water absorption and sensitivity to water. During the preparation process, the viscosity of the material is too large, which makes it difficult to prepare drug granules. The prepared losartan potassium preparation has the problem of unstable storage quality under high humidity conditions.
[0006] CN201110250254.5 discloses a method of wet granulation, the main preparation steps of which are to prepare blank granules first, and then mix the main drug losartan potassium and lubricant magnesium stearate with the blank granules. Magnesium fatty acid and the main drug Losartan Potassium are mixed evenly with other components, and an equal-volume incremental mixing method is adopted. Although this method achieves the purpose of mixing evenly, the long mixing process not only affects the preparation efficiency , It is also very easy to cause excessive mixing of magnesium stearate and losartan potassium to affect the dissolution of losartan potassium, thereby affecting the efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutic preparation of losartan potassium
  • Pharmaceutic preparation of losartan potassium
  • Pharmaceutic preparation of losartan potassium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024]

[0025] The preparation process comprises the following steps:

[0026] a. Fully mix losartan potassium, sodium lauryl sulfate, lactose, microcrystalline cellulose, calcium hydrogen phosphate, and sodium carboxymethyl starch (internal addition) to obtain a mixed powder;

[0027] b. Add absolute ethanol to the above mixed powder, sieve, dry, and granulate to obtain drug granules;

[0028] c. Mix magnesium stearate, sodium carboxymethyl starch (additional) and the drug granules in step b evenly, and fill the aforementioned mixture into capsules.

Embodiment 2

[0030]

[0031] The preparation process comprises the following steps:

[0032] a. Fully mix losartan potassium, sodium lauryl sulfate, lactose, microcrystalline cellulose, and calcium hydrogen phosphate to obtain mixed powder;

[0033] b. Add absolute ethanol to the above mixed powder, sieve, dry, and granulate to obtain drug granules;

[0034] c. Filling capsules with drug particles.

Embodiment 3

[0036]

[0037] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutic preparation of iosartan potassium, comprising losartan potassium, lactose, microcrystalline cellulose, calcium hydrophosphate and lauryl sodium sulfate, and prepared by the wet granulation technology. The pharmaceutic preparation has the advantage that high hydroscopicity of iosartan potassium can be improved, and the mixed materials have good flowability. Besides, the pharmaceutic preparation has high dissolution rate and good stability.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a losartan potassium pharmaceutical preparation and a preparation method of the pharmaceutical preparation. Background technique [0002] Hypertension is the most important risk factor leading to the occurrence and death of heart disease, cerebrovascular disease, and kidney disease. The purpose of antihypertensive drug therapy for hypertensive patients is to effectively prevent or delay stroke, myocardial infarction, The occurrence of cardiovascular and cerebrovascular complications such as heart failure and renal insufficiency can effectively control the disease process of hypertension and prevent the occurrence of severe hypertension such as hypertensive emergencies and sub-emergencies. [0003] Losartan potassium, also known as 2-butyl-4-chloro-1-([2'-(1H-tetrazole-5)(1,1''-biphenyl)-4-yl]methyl) -1H-imidazole-5-methanol monopotassium salt, is a new type of non-p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4178A61K9/48A61K47/22A61K47/02A61P9/12
CPCA61K9/1611A61K9/1617A61K31/4178
Inventor 产运霞耿玉先王彩平
Owner BEIJING WINSUNNY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products